Results From Study Of Mead Johnson’s Enfamil® Human Milk Fortifier Acidified Liquid Published In Pediatrics

Mead Johnson Nutrition (NYSE: MJN) announced today results of a new study published in Pediatrics that shows Enfamil Human Milk Fortifier Acidified Liquid supports significantly higher growth in premature infants than powdered fortifiers and is well-tolerated. Enfamil Human Milk Fortifier Acidified Liquid is the first and only ultra-concentrated liquid human milk fortifier marketed in the United States that meets safety guidelines from the Academy of Nutrition and Dietetics (AND) and Centers for Disease Control and Prevention (CDC), as well as new preterm nutrition guidelines from the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN).

The study is being released online today, and will appear in the October print edition of Pediatrics. It was also selected for presentation in December 2012 at Hot Topics, the nation’s premiere neonatal conference, with anticipated attendance of more than 1,000 neonatologists and perinatologists.

Breast milk provides important nutrients and immune factors to help meet the nutritional needs of infants and minimize the risk of illness and other complications. However, breast milk alone may not fully meet the nutritional needs of premature infants. 1 Even currently available powdered human milk fortifiers may not support the increased protein needs of low birth weight infants. 2 The CDC and AND have recommended that for premature or immune-compromised infants, sterile liquid products be used instead of powdered products in the NICU, where nutritionally appropriate. 3 Mead Johnson is the first company to make available an ultra-concentrated liquid fortifier with nearly 20 percent more protein than current powdered fortifiers when added to breast milk. This ultra-concentrated fortifier minimizes the dilution of breast milk and provides the higher protein levels needed by preterm infants.

“Although liquid fortifiers are already recognized as the new standard of care, this is the first study to demonstrate the nutritional and safety benefits of ultra-concentrated liquid human milk fortifiers over powdered versions,” said study co-author Carol Lynn Berseth, M.D., director of medical affairs, Mead Johnson Nutrition. “With the development of ultra-concentrated Enfamil Liquid Milk Fortifier, Mead Johnson continues to demonstrate its leadership in pediatric nutrition innovation.”

If you liked this article you might like

McCormick in $4.2 Billion Play for Reckitt Benckiser's Food Division

Reckitt Wrecked By Petya Virus

Reckitt Benckiser Says Petya Cyber Attack Will Slam Q2 Revenues

Reckitt to Close $18 Billion Mead Johnson Takeover Deal June 15